IFF recently announced that Dr. Gregory Yep, Chief R&D and Sustainability Officer has resigned effective 1 September to pursue a new opportunity in his professional journey. Yep will be succeeded by Dr. Casper Vroemen – Vice President of R&D, Health and Biosciences, who has dedicated his career to the advancement and commercialisation of biotechnology. Vroemen will be based in Union Beach, New Jersey, and will become part of IFF’s executive leadership team.
“Through Greg’s leadership, we have established IFF as the go-to partner for science-backed solutions for the health, fragrance, nutrition and home and personal care markets,” commented Frank Clyburn, CEO, IFF. “We thank Greg for his many contributions, and wish him well in his future endeavors. We have a strong successor in Casper, who will continue to advance our innovation pipeline and sustainability efforts.”
Vroemen joined the company in 2004 as a scientists and project leader. Over the last two decades, he has assumed roles of increasing responsibility in research and development in Europe and the US, and has played a major role in establishing IFF.
During his tenure, he oversaw the company’s position in protein engineering of industrial enzymes, contributed to the commercialisation of multiple new technological advancements and is a prolific inventor named on many patents.
As Chief R&D and Sustainability Officer at IFF, Vroemen will further IFF’s efforts in innovation, leading the company’s global R&D strategy, technological development, innovation pipeline and external collaborations. Vroemen holds a Master’s of Science in Molecular Life Sciences and a doctorate in Molecular Biology, both from Wageningen University in the Netherlands.
Stay up-to-date on the latest industry news and exclusives in our magazine.